The Cardiorenal Revolution: SGLT2s, HIF-PH Inhibitors, and Targeted Biologics Transforming Kidney Care
Global Chronic Kidney Disease (CKD) Drugs Market Set to Surpass USD 22.56 Billion by 2032 as Cardiorenal-Metabolic Therapies and Disease-Modifying Breakthroughs Reshape Nephrology PUNE, INDIA — The global clinical nephrology landscape is witnessing a foundational transition from symptomatic, late-stage disease management toward early, proactive disease modification. According to a...
0 Reacties 0 aandelen 5 Views 0 voorbeeld
Comunidad EDUCA https://comunidadeduca.com